Non-invasive Assessment of Intraocular Pressure in MPS by Use of the Ocular Response Analyzer.
MPSORA
Corneal-Compensated Intraocular Pressure, Corneal Hysteresis and Corneal Resistance Factor Measurements Performed With the Ocular Response Analyzer and Their Correlation to Conventional Goldmann Applanation Tonometry.
1 other identifier
observational
75
1 country
1
Brief Summary
The aim of the present study is to compare intraocular pressure (IOP) values assessed with Ocular Response Analyzer to the classical gold standard of IOP measurement, to Goldmann applanation tonometry by mucopolysacchyridosis-, Fabry-patients and healthy controls. We want to investigate biomechanical characteristics of the cornea and their influence on the IOP-measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 25, 2012
CompletedFirst Posted
Study publicly available on registry
September 27, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedMarch 1, 2013
February 1, 2013
1 year
September 25, 2012
February 28, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
agreement between ccIOP and GAT in MPS, Fabry and healthy controls
Evaluation of agreement between ccIOP and GAT in MPS, Fabry and healthy controls
Sep 2013 (anticipated)
Study Arms (3)
mucopolysaccharidosis
mucopolysaccharidosis
Fabry disease
Fabry disease
healthy controls
healthy controls
Eligibility Criteria
25 eyes of MPS patients 25 eyes of Fabry patients 25 eyes of healthy age matched controls (a difference of ± 5 years in the mean between both groups is accepted)
You may qualify if:
- MPS I, II, IV, VI patients with at least grade 3 of corneal clouding (Couprie et al.)
- Fabry patients with cornea verticillata \> grade 1
- Age ≥ 12 years
- Patient is able to comply with the study procedure
- Patient has consented to be in the trial
- Ability to fixate a target
You may not qualify if:
- History of corneal transplantation or refractive surgery
- Corneal pathologies other than MPS-associated corneal opacity
- Corneal, conjunctival or intraocular inflammation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Ophthalmology, University Medical Center, Johannes Gutenberg-
Mainz, 55131, Germany
Related Publications (1)
Wasielica-Poslednik J, Politino G, Schmidtmann I, Lorenz K, Bell K, Pfeiffer N, Pitz S. Influence of Corneal Opacity on Intraocular Pressure Assessment in Patients with Lysosomal Storage Diseases. PLoS One. 2017 Jan 12;12(1):e0168698. doi: 10.1371/journal.pone.0168698. eCollection 2017.
PMID: 28081172DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susanne Pitz, MD
Department of Ophthalmology, University Medical Center, Johannes Gutenberg-
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
September 25, 2012
First Posted
September 27, 2012
Study Start
September 1, 2012
Primary Completion
September 1, 2013
Last Updated
March 1, 2013
Record last verified: 2013-02